ATE271875T1 - Verwendung von ketoliden zur vorbeugung von mit atherosklerose zusammenhängender thrombotischer komplikationen - Google Patents

Verwendung von ketoliden zur vorbeugung von mit atherosklerose zusammenhängender thrombotischer komplikationen

Info

Publication number
ATE271875T1
ATE271875T1 AT98955662T AT98955662T ATE271875T1 AT E271875 T1 ATE271875 T1 AT E271875T1 AT 98955662 T AT98955662 T AT 98955662T AT 98955662 T AT98955662 T AT 98955662T AT E271875 T1 ATE271875 T1 AT E271875T1
Authority
AT
Austria
Prior art keywords
ketolides
atherosclerosis
complications associated
thrombotic complications
preventing thrombotic
Prior art date
Application number
AT98955662T
Other languages
German (de)
English (en)
Inventor
Francis Petit
Francoise Vacheron
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE271875T1 publication Critical patent/ATE271875T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT98955662T 1997-11-17 1998-11-16 Verwendung von ketoliden zur vorbeugung von mit atherosklerose zusammenhängender thrombotischer komplikationen ATE271875T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
PCT/FR1998/002436 WO1999025365A1 (fr) 1997-11-17 1998-11-16 Utilisation des ketolides pour prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (1)

Publication Number Publication Date
ATE271875T1 true ATE271875T1 (de) 2004-08-15

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98955662T ATE271875T1 (de) 1997-11-17 1998-11-16 Verwendung von ketoliden zur vorbeugung von mit atherosklerose zusammenhängender thrombotischer komplikationen

Country Status (35)

Country Link
US (1) US20080139489A1 (enExample)
EP (1) EP1030673B1 (enExample)
JP (1) JP4550273B2 (enExample)
KR (1) KR20010032130A (enExample)
CN (1) CN1286633A (enExample)
AP (1) AP1196A (enExample)
AR (1) AR014119A1 (enExample)
AT (1) ATE271875T1 (enExample)
AU (1) AU744419B2 (enExample)
BG (1) BG104427A (enExample)
BR (1) BR9814199A (enExample)
CA (1) CA2312021C (enExample)
DE (1) DE69825308T2 (enExample)
DZ (1) DZ2654A1 (enExample)
EA (1) EA003322B1 (enExample)
EE (1) EE04095B1 (enExample)
ES (1) ES2224446T3 (enExample)
FR (1) FR2771008B1 (enExample)
GE (1) GEP20032968B (enExample)
HR (1) HRP20000314A2 (enExample)
HU (1) HUP0004507A3 (enExample)
ID (1) ID24940A (enExample)
IL (1) IL136149A0 (enExample)
MA (1) MA26566A1 (enExample)
NO (1) NO20002435L (enExample)
NZ (1) NZ504305A (enExample)
OA (1) OA11411A (enExample)
PL (1) PL340373A1 (enExample)
SK (1) SK7042000A3 (enExample)
TN (1) TNSN98206A1 (enExample)
TR (1) TR200001384T2 (enExample)
TW (1) TW472061B (enExample)
WO (1) WO1999025365A1 (enExample)
YU (1) YU29600A (enExample)
ZA (1) ZA9810357B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
ATE344269T1 (de) * 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
EP1147121B1 (en) * 1999-01-27 2003-12-17 Pfizer Products Inc. Ketolide antibiotics
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
MXPA02009816A (es) 2000-04-04 2003-03-27 Smithkline Beecham Plc Derivados de carbamato de 2-hidroxi-multilina para uso antibacteriano.
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
KR20130120458A (ko) * 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424187A (en) * 1991-06-14 1995-06-13 Board Of Regents Of The University Of Washington Method of screening for arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
BR9814199A (pt) 2000-09-26
IL136149A0 (en) 2001-05-20
HUP0004507A3 (en) 2001-12-28
ZA9810357B (en) 1999-11-12
OA11411A (fr) 2004-04-20
US20080139489A1 (en) 2008-06-12
FR2771008B1 (fr) 2000-04-28
ID24940A (id) 2000-08-31
GEP20032968B (en) 2003-05-27
CA2312021A1 (fr) 1999-05-27
MA26566A1 (fr) 2004-12-20
CN1286633A (zh) 2001-03-07
KR20010032130A (ko) 2001-04-16
CA2312021C (fr) 2008-08-26
NZ504305A (en) 2002-11-26
EA003322B1 (ru) 2003-04-24
YU29600A (sh) 2003-02-28
EE04095B1 (et) 2003-08-15
SK7042000A3 (en) 2000-12-11
JP2001523644A (ja) 2001-11-27
DE69825308D1 (de) 2004-09-02
NO20002435L (no) 2000-07-07
BG104427A (en) 2001-02-28
EP1030673B1 (fr) 2004-07-28
DZ2654A1 (fr) 2003-03-22
JP4550273B2 (ja) 2010-09-22
AU1242599A (en) 1999-06-07
EA200000531A1 (ru) 2000-10-30
AU744419B2 (en) 2002-02-21
HRP20000314A2 (en) 2001-02-28
EP1030673A1 (fr) 2000-08-30
HUP0004507A1 (hu) 2001-05-28
PL340373A1 (en) 2001-01-29
TR200001384T2 (tr) 2001-06-21
EE200000244A (et) 2001-06-15
FR2771008A1 (fr) 1999-05-21
AP1196A (en) 2003-08-18
DE69825308T2 (de) 2005-08-04
NO20002435D0 (no) 2000-05-11
ES2224446T3 (es) 2005-03-01
WO1999025365A1 (fr) 1999-05-27
AP2000001825A0 (en) 2000-06-30
TNSN98206A1 (fr) 2005-03-15
AR014119A1 (es) 2001-02-07
TW472061B (en) 2002-01-11

Similar Documents

Publication Publication Date Title
ATE233241T1 (de) Stabile reagenzien zur herstellung von radiopharmazeutika
DE69414543D1 (de) Verwendung von Zusammensetzungen zur Schaumregulierung
DE69735359D1 (de) System zur auswahl von produkten
DE69427029D1 (de) Verfaheren zur verbrennungsmotorsteuerung
DE69804506D1 (de) Verfahren zur herstellung von mit karbonat und magnesium substituiertem hydroxyapatit
ATE291897T1 (de) Verwendung von zusammensetzungen mit stabilisierten enzymen
DE69913030D1 (de) Verfahren zur Regelung einer Verbrennung
DE69813278T2 (de) Calciumkomplexe zur stärkung von nahrungsmitteln
ID26161A (id) Serat poliester dan metode untuk membuatnya
EP1082402A4 (en) Process for the production of high lubricity low sulfur distillate fuels
DE69516835D1 (de) Kabel zur Ueberwachung des Schiefstandes von benachbarten Tragflächen
DE69728841D1 (de) Verfahren zur Übertragung von Adressdaten
ATE309350T1 (de) Verfahren zur herstellung von polypeptiden mit geeigneter glykosilierung
ATE207732T1 (de) Zusammensetzung zur remineralisierung
DE69414404D1 (de) Verfahren zur Kontrolle von Biolumineszenz
DE69811802D1 (de) Verfahren zur Transesterification
DE69710479D1 (de) Organomineralgel zur dekontamination von oberflächen
DE69612888D1 (de) Techniken zur Regelung von entfernten Lampenlasten
DE69802534D1 (de) Verfahren zur herstellung von fluorkohlenwasserstoffen
DE69511878D1 (de) Verfahren zur nassentschwefelung von rauchgasen mit kalkstein
DE59708157D1 (de) System zur Form- und Farbstrukturbestimmung von Zähnen
DE59710206D1 (de) Verfahren zur Polykondensation von Polyester
DE69721994D1 (de) System zur befestigung von plattenförmigen material
DE69529343D1 (de) Verfahren zur isolierung von mesophasepech
DE59802737D1 (de) Verfahren zur kontinuierlichen herstellung von dihydroxydiarylalkanen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties